chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Blackouts; Seizures; Has no taste buds; has no appetite; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LOSS OF CONSCIOUSNESS (medically significant), outcome "unknown", described as "Blackouts"; SEIZURE (medically significant), outcome "unknown", described as "Seizures"; AGEUSIA (non-serious), outcome "unknown", described as "Has no taste buds"; DECREASED APPETITE (non-serious), outcome "unknown", described as "has no appetite". She is reporting an adverse event after having Pfizer Covid-19 Vaccine. She mentioned she is having blackouts and seizures. They clarified that they may file a lawsuit if it gets to that point. They clarified that this is not a life to live, they have blackouts or seizures or both or who knows what, nobody knows what they have. They have been calling numbers for 2 years. They have not had a taste of a hamburger, has no taste buds, has no appetite. She was not getting the booster and only got first and second dose of the Pfizer COVID Vaccine. She mentioned two different types of side effects, the adverse event and side effect from the vaccine and she wants information regarding those. Caller is stating that she is having "adverse event-side effect" from the vaccine. Caller narrated that she's been experiencing side effect/adverse event for 3 years and she has seen neurologist for the past 2 years, but they can't figure out what's wrong with her. She also mentioned that her healthcare providers don't have enough information whether what she is experiencing is side effect. Caller mentioned having blackout and seizures. She's been experiencing it for the past 3 years. She's been experiencing blackouts and siezures. Caller also mentioned that on 11Dec, she ended up on a lake (was not verified) and she didn't realize until she was anchored in the lake; stating her kids could have lost their mother. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
The patient came in with a larger red area where she got her ZOSTAVAX. She said it felt warm to the touch and was a little itchy. She said it was fine after she got it and showed up after about a day or so.  She did pilates yesterday and the red spot has gotten bigger since.
Hoarseness for several days and arm ached like a toothache for several days/weeks. Patient was advised by physician to use ibuprofen as directed and to not finish vaccine series.
stated patient is very pale, feels like she is going to pass out and that she felt hot. I asked if they had a thermometer to take her temp, this was 97.7. She had something to eat when she got home after her vaccines around 5 and has been drinking fluids, no strenuous activities.
Mother advised child received routine 18 month vaccinations HepA to right leg and PEDIARIX (DTaP, IPV, & HepB) to left leg on 1/27/2012. He was in good health with pre-existing keratosis pilaris and eczema to both legs when given (normal skin for him). Mom advised no prior reactions to other childhood vaccinations (specifically PEDIARIX). Approximately 1/29/2012 (day 2), mom advised he developed a fever (100.1 rectal) with warm -hot redness and swelling to his left thigh vaccine injection site (pictures taken). (He had no reaction to right thigh vaccination site.) He was seen by nearby ER 1/30/2012 with temperature 98.7F being diagnosed with left leg rash and inflammatory reaction from vaccination. Mom was advised to monitor and follow up with PCP 1/31/12. PCP placed child on antibiotics (cephalexin) for possible cellulitis as redness had expanded past margins marked by ER. Mom said rash was markedly improved after one dose of antibiotic. 2/1/2012 exam by provider noted 5x10cm erythematous area to anterior left thigh that was pale red with no increase in marked margins 1/31/12. Skin was warm to touch (similar to surrounding skin) with no induration or swelling palpated. Site blanched to touch and child noted to move extremity, stand and bend without distress. There were multiple fine pinprick macules to lateral thigh adjacent to marked erythematous area. Mom advised this was his normal keratosis pilaris and eczema reactions present prior to vaccinations. 2/3/2012 follow up with PCP noted complete resolution of redness and swelling with provider diagnosing as allergic reaction possible cellulitis. Follow up on 2/7/2012 found child happy and playful with no further skin reactions.
Fever/ chills that night and lessened during next day but skin still sensitive.  Right sides facial skin. Tenderness  yesterday  with now stabbing facial pain right cheek/ jaw and ear.
Headache, Myalgia, Nausea Vomiting, sore arm, arm pain Narrative:
Bell's Palsy; This spontaneous report as received from a lawyer refers to a female patient (pt) of unknown age. Medical history, concurrent conditions, and concomitant medication were not reproted. In or around 03-NOV-2017, the patient was vaccinated with a dose of zoster vaccine live(ZOSTAVAX) (Dose, lot number, and expiration date  were not provided) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). Shortly after receiving pt's zoster vaccine live(ZOSTAVAX) vaccine, she suffered a sudden onset of left-sided facial paralysis and was diagnosed with Bell's Palsy.  As a direct and proximate result of zoster vaccine live(ZOSTAVAX), the pt's symptoms have resulted in physical limitations not present prior to using zoster vaccine live(ZOSTAVAX). She experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live(ZOSTAVAX), she sustained severe and permanent personal injuries. Further, as a tragic consequence of zoster vaccine live(ZOSTAVAX)wrongful conduct, the pt suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. Upon internal review Bell's Palsy was considered as medically significant and disabling event.
The day after receiving my 2nd shot at 0413am I started experiencing hot flashes. First they were mild and intermittent but as the morning went on the hot flashes intensified and became more constant causing severe nausea and dry heaving.
Pt recv vax on 10/14/97; immediately post vax pt exp red, swollen vax site w/ pain; 1 wk post vax pt exp discolored vax sited w/ warmth; tx=Benadryl
Local reaction, erythema, 1/4cm, swelling size of a grape. 3 episodes vomiting, 2 of diarrhea. Pt had unconfirmed case of Pertussis after 2nd round of Pediarix, Pedvax Hib and Prevnar. Neg PCR essay for pertussis. Lab questioned verocity of given length sample which caused it and that it was taken after initiating abx therapy.
1APR92 onset of rt front hip pain & stiffness-lasted until 4APR93; 4APR93 onset of lt knee pain &s tiffness still present as of 7APR93; lt ear lump behind ear not painful;
Covid Positive; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid Positive) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Hypertension since 1995.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced COVID-19 (Covid Positive). The patient was treated with MONOCLONAL ANTIBODY 17-1A (intravenous) 28-Jan-2021 for SARS-CoV-2 infection, at a dose of 1 dosage form. At the time of the report, COVID-19 (Covid Positive) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Jan-2021, SARS-CoV-2 test: positive (Positive) RT-PCR positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment reported   This case was linked to MOD-2021-063975 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-Jun-2021: Follow-up information received on 27-JUN-2021, it had Historical condition, treatment date,COVID-19 symptoms experienced by the patient were updated.
Red papule with white center the size of eraser head of pencil.  Appeared to left side fo face next to chin area 30-45 minutes post vaccination.  Denies other symptoms.
difficulty sleeping; increased anxiety; little headache; rapid heart beats; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (rapid heart beats), INSOMNIA (difficulty sleeping), ANXIETY (increased anxiety) and HEADACHE (little headache) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     Concurrent medical conditions included Anxiety. Concomitant products included ATORVASTATIN CALCIUM (LIPITOR) for Cholesterol blood increased, CALCIUM for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced HEART RATE INCREASED (rapid heart beats) and HEADACHE (little headache). On an unknown date, the patient experienced INSOMNIA (difficulty sleeping) and ANXIETY (increased anxiety). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Adverse event, at an unspecified dose and frequency. On 28-Feb-2021, HEART RATE INCREASED (rapid heart beats) and HEADACHE (little headache) had resolved. At the time of the report, INSOMNIA (difficulty sleeping) and ANXIETY (increased anxiety) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: increased (High) rapid heart rate.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included Remtron 15 milligram for anxiety   This case was linked to MOD-2021-259098 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021: Follow up received : Address, demographic details, race were added. Medical history, dose information, concomitant medication were added, Events outcome was updated to recovered, new events insomnia, anxiety were added.
Started pains in my right rear calf. Could not walf for extended length and became short of breath. Admitted to Hospital three days March 29, 2021 to April 1, 2021   Block 21 does not allow me to input the info noted above.
administered frozen Shingrix.; This case was reported by a nurse via call center representative and described the occurrence of incorrect storage of drug in a 61-year-old female patient who received Herpes zoster (Shingrix) (batch number C43KM, expiry date 10th April 2023) for prophylaxis.   In March 2022, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.   Additional Information: GSK Receipt Date: 7-Apr-2022 Reporter's comments: The nurse administered frozen Shingrix vaccine to the patient within 7th March 2022 to 31st March 2022. The healthcare professional provided consent to follow up. Information within adverse event report was all the healthcare professional provided at this time. Additional Supportive Information: The patient received frozen Shingrix vaccine which led incorrect storage of drug. This was 1 of the 11 cases, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022061870:Same reporter. US-GLAXOSMITHKLINE-US2022061866:Same reporter. US-GLAXOSMITHKLINE-US2022061868:Same reporter US-GLAXOSMITHKLINE-US2022061865:Same reporter. US-GLAXOSMITHKLINE-US2022061860:Same reporter. US-GLAXOSMITHKLINE-US2022061864:Same reporter. US-GLAXOSMITHKLINE-US2022061871:Same reporter. US-GLAXOSMITHKLINE-US2022061873:Same reporter. US-GLAXOSMITHKLINE-US2022061874:Same reporter. US-GLAXOSMITHKLINE-US2022061875:Same reporter.
Vaccine MENACTRA adm. 8/14/2018, (L) deltoid region became red/pink warm. Size 10cm W x 10.5cm long - using ice and ibuprofen, seen in office 8/17/18.
First felt pressure on right side of head on Tuesday May 4th.  Took Vaccine on Sunday May 9th. Experienced fever, chills, and dizziness until Tuesday May 11th. Noticed head pressure increase and spread to left side of head and top side of head on Thursday May 13th. Noticed head pressure spread to back of head on Friday May 14th. Pressure and tenderness on all sides of head, with pulsating superficial veins make it difficult to sleep, as pain increases in conjunction with amount of time resting head on pillow. ER doc persribed fioricet on Wednesday May 19th. Felt tingling and numbness down left side of body in reaction to it on Friday, May 21st. Visited ER on May 21st, and received migraine cocktail. Helped relieve pain so that I could lay my head down to rest, but did not stop pulsating throbbing of superficial head veins. May 24th, neurologist prescribes steroids for pain and inflammation, and sleep medication so I could sleep. Sleep noticeably improved. Still testing out 50mg dose of steroids. Steroids noticeably do nothing for pulsating throbbing superficial veins.  *Note: I worry this vaccine may have exacerbated the headache I was feeling prior to my vaccination, or that the vaccination was fine, and what I am experiencing now is merely a extension of the headache I was feeling prior to vaccination.
I had my shot on a Thursday morning , Dec. 30, at 10:00 AM.  On Friday, Dec. 31, I noticed both ears started ringing in the morning.  It has not gone away and it's been one week.
internal discomfort (pain almost felt like cramping) in the surgical area; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (internal discomfort (pain almost felt like cramping) in the surgical area) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     The patient's past medical history included Hysterectomy on 30-Mar-2021.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, the patient experienced MUSCLE SPASMS (internal discomfort (pain almost felt like cramping) in the surgical area). On 11-Apr-2021, MUSCLE SPASMS (internal discomfort (pain almost felt like cramping) in the surgical area) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       It is reported that the consumer had a hysterectomy on 30-MAR-2021 and the day after receiving her first dose of the vaccine on 09-APR-2021 she experienced pain that felt like cramping in the surgical area.  She did not seek medical attention for this event but treated this pain with Tylenol and Advil and the pain resolved on 11-APR-2021.  No concomitant medications were reported. No treatment medication details provided.
In evening pt told mom arm hurt and warm, tender to touch. Temp 100.4. Mom gave Tylenol every 6  hours. Came to clinic in AM. Upper left outer arm is swollen slighlty and warm and tender to touch. Temp 97.1.
vertigo; balance loss; dizziness and lightheadedness; arm soreness at injection site/"it hurts" when touched or arm raised above the shoulder; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (vertigo), BALANCE DISORDER (balance loss), DIZZINESS (dizziness and lightheadedness) and INJECTION SITE PAIN (arm soreness at injection site/"it hurts" when touched or arm raised above the shoulder) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     Concurrent medical conditions included Vertigo. Concomitant products included DIAZEPAM for Vertigo.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced INJECTION SITE PAIN (arm soreness at injection site/"it hurts" when touched or arm raised above the shoulder). On 09-Mar-2021, the patient experienced VERTIGO (vertigo), BALANCE DISORDER (balance loss) and DIZZINESS (dizziness and lightheadedness). The patient was treated with DIAZEPAM at a dose of quarter tablet. On 14-Mar-2021, VERTIGO (vertigo), BALANCE DISORDER (balance loss) and DIZZINESS (dizziness and lightheadedness) had resolved. At the time of the report, INJECTION SITE PAIN (arm soreness at injection site/"it hurts" when touched or arm raised above the shoulder) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  Concomitant medications also included cholesterol medication.  Patient developed symptoms of arm soreness at injection site on 06-MAR-2021 Saturday and 07-MAR-2021 Sunday. Also mentioned as "it hurts" when touched or arm raised above the shoulder. By Monday midnight and Tuesday early morning i.e. on 09-MAR-2021, patient started to experience symptoms like, vertigo, balance loss, dizziness, and lightheadedness. All these symptoms lasted for 5 days and now no symptoms persisting. Patient did quote " This is not the typical vertigo symptom I would experiences often."
Experiencing itching, hive like, 1-2 weeks after getting the second shot; Experiencing itching, hive like, 1-2 weeks after getting the second shot; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Experiencing itching, hive like, 1-2 weeks after getting the second shot) and URTICARIA (Experiencing itching, hive like, 1-2 weeks after getting the second shot) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 042L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRURITUS (Experiencing itching, hive like, 1-2 weeks after getting the second shot) and URTICARIA (Experiencing itching, hive like, 1-2 weeks after getting the second shot). At the time of the report, PRURITUS (Experiencing itching, hive like, 1-2 weeks after getting the second shot) and URTICARIA (Experiencing itching, hive like, 1-2 weeks after getting the second shot) outcome was unknown. Not Provided          No relevant concomitant medications were reported. The patient did not take any treatment medication. Action taken with mRNA-1273 in response to the events was not applicable.
Patient reported 3 to 4 hours after administration of vaccination starting with 101 degree fever and chills achy body and fatigue symptoms that lasted a full 24 hours.
Pt received monoclonal antibody the day after becoming positive, and was at the hospital for increased shortness of breath and was found to be hypoxic.
Redness, swelling, itching at injection site,  Patient was advised to take Benadryl and apply ice.  Symptoms improved the next day with the benadry and the ice.  Symptoms resolves 2 days after administration.
MINIMAL SIDE EFFECTS; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 29-JUN-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced minimal side effects. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of minimal side effects was not reported. This report was non-serious.
This spontaneous report as received from a nurse refers to an un patient of unknown age. The patient's medical history and concurrent conditions were not provided. The nurse reported that an unknown number of unspecified patients on unspecified dates reported contracting mumps after having a prior history of vaccination with either properly stored M-M-R II or properly stored PROQUAD (vaccination date, dose, route of administration, lot numbers, expiration dates were not reported for both vaccines) or both. The nurse confirmed that the vaccinations were historical in these cases, not necessarily recent. The nurse reporter also stated that there was a mumps outbreak in an unspecified geographic area affecting these particular patients. The outcome of mumps was unknown. Causality assessment was not reported. Additional information is not expected, because the reporter did not wish to be contacted.
PUI is still hospitalized at Hospital. PUI has a compromised immune system and takes Prednisone for ulcerative colitis. She is long term case taking Prednisone. PUI thought she had a sinus infection and went to her primary care physician and was given rounds of doxycycline and did not improve. PUI began having shortness of breath. PUI went to Family Care where she tested positive for Covid-19 and was given steroids and an inhaler and sent home. PUI did not improve and ended up in the emergency room at Hospital where they tested her and sent her to Hospital another location to receive Monoclonal antibody treatment for five days. PUI was on oxygen until today when she started to improve.
Patient reports that 3-4 days after his vaccination, he developed facial sores, a severe, persistent headache, and swollen, sore gums. Patient went to his dentist thinking he had an infected tooth, which he did not.  He was prescribed prednisone, valacyclovir, and furosemide at that time and said that symptoms have still not improved when he reported this reaction to our pharmacy on 3-6-21.
Patient received a bottle of undiluted Pfizer Pedi COVID Vaccination in the morning from the RN.  When there were no more doses left after four doses were given, this was report to the RN.  There were no adverse reactions observed or reported in the patient observation area today.  This medication error was reported to me and immediately escalated to our director at 9:15am.  The nursing director advised us to contact the Infectious Disease Physician for next step.  Dr. advised contacting Dr., Pedicatric Infectious Disease.  Dr. informed that four patients received 0.75mcg instead of 0.3mcg of Pedi Pfizer vaccination this morning.  Dr. consulted:  1. No particular action to be done at this point except to contact the parents and make them aware to monitor for the same potential side effect (fever, headache, etc.).   2. Reassure parent/guardian that their child received a lower dose than a teen or adolescent would have received, even with this extra dose.   3. Patient is at higher risk for these reactions, but he is not particularly concerned from a vaccine standpoint.   4. If patient experiences any significant side effects, have physician evaluate.   5.  Continue with second dose as usual, unless strong reaction from this dose.
Fever, chills, muscle aches and stomach cramps for 36 hours. Tylenol was used to help fever